Silke Mainka, M.B.L.-HSG

Member

Silke Mainka
  • Year of birth 1970
  • Nationality German
  • Place of residence Neukirch, Germany
  • Initial appointment 2024
  • End of current period 2024

Professional Development

Since 2022 Country and Innovative Medicines Ethics, Risk & Compliance Head / authorized signatory of Novartis Pharma GmbH Novartis, Germany

2018 - 2022 Head Legal, Ethics, Risk & Compliance / authorized signatory of Novartis Pharma GmbH Novartis Oncology, Germany

2017 - 2018 General Counsel Global Nutritional Health Business, Head Legal Export Markets, UK & Ireland Eli Lilly & Company/Elanco Animal Health, USA

2015 - 2017 General Counsel Global Emerging Businesses Eli Lilly & Company/Elanco Animal Health, USA

2015 Head Legal DACH, BeNeLux & Nordics Eli Lilly & Company/Elanco Animal Health, Germany

2013 - 2014 Head Legal & Compliance Germany & Austria Data Privacy Officer Novartis Animal Health, Germany

2012 - 2015 Legal Advisor, Corporate Legal Biopharma / Strategic Alliances & Transaction Boehringer Ingelheim Pharma, Germany

2000 - 2012 Legal Advisor, Trustees & Management Team Vetter Pharma, Germany

Since 1997 Partner and owner, Law Firm Bott, Eber & Mainka / Law Firm Mainka, Germany

1995 Legal Counsel Law Firm Radon & Ishizumi N.Y., USA

Education

2007 - 2009 Master of European and International Business Law University of St. Gallen (HSG), Switzerland

1998 - 1999 Specialist Lawyer Degree for social law German Lawyers' Institute, Germany

1997 Second State Examination in law Regional Court Ravensburg / Higher Regional Court Stuttgart / Law Firm Bongen, Renaud & Partner, Germany

1994 First State Examination in law Eberhard-Karls-University of Tuebingen, Germany

1990 A-levels Montfort-Gymnasium Tettnang, Germany